Depression symptoms 6 years after stroke are associated with higher perceived impact of stroke, limitations in ADL and restricted participation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 05 2022
Historique:
received: 02 11 2021
accepted: 15 04 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Late post-stroke depression symptoms are understudied. This study aimed to investigate depression symptoms 6 years after stroke, and associations with perceived impact of stroke, activities of daily living (ADL), and participation in social and everyday activities. Data was collected in a 6-year follow-up in a longitudinal study of stroke. Assessments included Hospital Anxiety and Depression Scale (HADS) for depression symptoms, Stroke Impact Scale 3.0. for perceived impact of stroke, Barthel Index for ADL, Frenchay Activities Index for participation in social and everyday activities. The research questions were addressed by bivariate analyses (with HADS-D ≥ 4 as cut-off), and hierarchical multiple regression analyses using continuous HADS-D scores. Forty percent of the 105 participants (57% men, age 30-91) showed depression symptoms (HADS-D ≥ 4). Depression symptoms were associated with higher perceived impact of stroke, more dependence in ADL, and more restrictions in participation in social and everyday activities. Most of those with depression symptoms had low scores on HADS, indicating that even mild depression symptoms might be relevant to identify and target in treatment and rehabilitation of long-term consequences of stroke.

Identifiants

pubmed: 35551206
doi: 10.1038/s41598-022-11097-9
pii: 10.1038/s41598-022-11097-9
pmc: PMC9098872
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7816

Informations de copyright

© 2022. The Author(s).

Références

Int J Stroke. 2021 Jul;16(5):510-518
pubmed: 33527880
PLoS One. 2015 Dec 10;10(12):e0144344
pubmed: 26658735
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Int J Stroke. 2014 Dec;9(8):1026-36
pubmed: 25156411
Disabil Rehabil. 2016 Oct;38(20):2028-37
pubmed: 26729231
Int Rehabil Med. 1985;7(4):176-81
pubmed: 4093249
PLoS One. 2019 Jul 8;14(7):e0219513
pubmed: 31283800
J Affect Disord. 2018 Aug 1;235:589-596
pubmed: 29704854
Stroke. 2017 Feb;48(2):e30-e43
pubmed: 27932603
Stroke. 2018 Dec 7;:STROKEAHA118022913
pubmed: 30580719
Cochrane Database Syst Rev. 2020 Aug 6;8:CD013461
pubmed: 32841367
J Psychosom Res. 2009 Oct;67(4):325-32
pubmed: 19773025
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Arch Phys Med Rehabil. 2003 Jul;84(7):950-63
pubmed: 12881816
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Int J Stroke. 2014 Dec;9(8):1017-25
pubmed: 25117911
J Neurol Sci. 2012 Feb 15;313(1-2):160-6
pubmed: 21937062
PLoS Med. 2011 May;8(5):e1001033
pubmed: 21610863
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Health Qual Life Outcomes. 2017 Oct 4;15(1):193
pubmed: 28978356
Stroke. 2009 Oct;40(10):3396-9
pubmed: 19661471
JAMA Psychiatry. 2018 Apr 1;75(4):336-346
pubmed: 29450462
Stroke. 1985 Sep-Oct;16(5):885-90
pubmed: 3901425
Br J Psychiatry. 2013 Jan;202(1):14-21
pubmed: 23284148
Stroke. 2013 Apr;44(4):1105-10
pubmed: 23404719
Arch Phys Med Rehabil. 2015 Jul;96(7):1329-38
pubmed: 25596001
Cochrane Database Syst Rev. 2020 May 11;5:CD003689
pubmed: 32390167
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944

Auteurs

Charlotte Ytterberg (C)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet 23100, 141 83, Huddinge, Sweden.
Karolinska University Hospital, Stockholm, Sweden.

Linda Cegrell (L)

Department of Physiotherapy, Capio S:t Görans Hospital, Stockholm, Sweden.

Lena von Koch (L)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet 23100, 141 83, Huddinge, Sweden.
Karolinska University Hospital, Stockholm, Sweden.

Maria Wiklander (M)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet 23100, 141 83, Huddinge, Sweden. maria.wiklander@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH